Literature DB >> 20136479

Guanfacine overdose resulting in initial hypertension and subsequent delayed, persistent orthostatic hypotension.

Alicia B Minns1, Richard F Clark, Aaron Schneir.   

Abstract

INTRODUCTION: Guanfacine is an alpha(2)-adrenoreceptor agonist used for the treatment of attention-deficit hyperactivity disorder and tic disorders. Few reports exist regarding overdose with guanfacine. CASE REPORT: A 16-year-old female with Tourette's syndrome presented with diaphoresis, dry mouth, and hypertension 8 h after ingesting 25 mg of guanfacine. These symptoms improved and her blood pressure (BP) normalized over 2 h. Thirty hours following ingestion, she experienced near syncope and returned to the emergency department. She was noted to have orthostatic hypotension and a prolonged QTc interval of 593 ms on electrocardiogram. With only fluid support, she was asymptomatic by 60 h postingestion and her QTc interval had improved to 511 ms. DISCUSSION: This experience suggests a much delayed onset of symptoms may occur and that the QTc interval may be prolonged, necessitating a longer period of monitoring in a patient presenting with an overdose.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136479     DOI: 10.3109/15563650903505174

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  6 in total

1.  Prolonged bradycardia and hypotension following guanfacine extended release overdose.

Authors:  Jennifer Walton; Michelle Byrum; Amanda Shumaker; Daniel L Coury
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-07-10       Impact factor: 2.576

2.  A case of sinus pause induced by swallowing in the setting of olanzapine and guanfacine overdose.

Authors:  Andrew R Kolarich; Matthew Mubarak; Shannon Wells; Christopher T Campbell; Ravi S Samraj
Journal:  J Intensive Care Soc       Date:  2018-07-05

Review 3.  Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes.

Authors:  Jose Martinez-Raga; Amparo Ferreros; Carlos Knecht; Raquel de Alvaro; Eloisa Carabal
Journal:  Ther Adv Drug Saf       Date:  2016-11-29

Review 4.  Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.

Authors:  Henry A Spiller; Hannah L Hays; Alfred Aleguas
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

5.  Delayed Signs and Symptoms of Extended Release Guanfacine Overdose in Two Adolescent Patients: Implications of Monitoring on the Psychiatry Unit.

Authors:  Sanskriti Mishra; Julia Shekunov; Della J Derscheid; Elizabeth A Canterbury; Jonathan G Leung
Journal:  Case Rep Psychiatry       Date:  2022-03-25

6.  A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity.

Authors:  Magdalena Dudek; Joanna Knutelska; Marek Bednarski; Leszek Nowiński; Małgorzata Zygmunt; Barbara Mordyl; Monika Głuch-Lutwin; Grzegorz Kazek; Jacek Sapa; Karolina Pytka
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.